» Articles » PMID: 26679521

The Ubiquitin Ligase Smurf2 Suppresses TGFβ-induced Epithelial-mesenchymal Transition in a Sumoylation-regulated Manner

Overview
Specialty Cell Biology
Date 2015 Dec 19
PMID 26679521
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT) is a fundamental cellular process in epithelial tissue development, and can be reactivated in cancer contributing to tumor invasiveness and metastasis. The cytokine transforming growth factor-β (TGFβ) is a key inducer of EMT, but the mechanisms that regulate TGFβ-induced EMT remain incompletely understood. Here, we report that knockdown of the ubiquitin ligase Smurf2 promotes the ability of TGFβ to induce EMT in a three-dimensional cell culture model of NMuMG mammary epithelial cells. In other studies, we identify Smurf2 as a target of the small ubiquitin like modifier (SUMO) pathway. We find that the SUMO-E2 conjugating enzyme Ubc9 and the SUMO E3 ligase PIAS3 associate with Smurf2 and promote its sumoylation at the distinct sites of Lysines 26 and 369. The sumoylation of Smurf2 enhances its ability to induce the degradation of the TGFβ receptor and thereby suppresses EMT in NMuMG cells. Collectively, our data reveal that Smurf2 acts in a sumoylation-regulated manner to suppress TGFβ-induced EMT. These findings have significant implications for our understanding of epithelial tissue development and cancer.

Citing Articles

Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy.

Youssef E, Zhao S, Purcell C, Olson G, El-Deiry W Front Oncol. 2024; 14:1484515.

PMID: 39697237 PMC: 11652374. DOI: 10.3389/fonc.2024.1484515.


The regulatory roles of Smad2/3 protein and gene expression in granulosa cells of germinal vesicle and metaphase II oocytes in polycystic ovarian syndrome: A case-control study.

Ghorbani M, Farimani M, Khodadadi I, Mohagheghi S, Amiri I, Tayebinia H Int J Reprod Biomed. 2024; 22(6):441-450.

PMID: 39205921 PMC: 11347763. DOI: 10.18502/ijrm.v22i6.16794.


Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma.

Li C, Zhang E, Ye Y, Xiao Z, Huang H, Zeng Z Sci Rep. 2024; 14(1):14051.

PMID: 38890507 PMC: 11189538. DOI: 10.1038/s41598-024-64907-7.


Distinctive tumorigenic significance and innovative oncology targets of SUMOylation.

Zhou H, Deng N, Li Y, Hu X, Yu X, Jia S Theranostics. 2024; 14(8):3127-3149.

PMID: 38855173 PMC: 11155398. DOI: 10.7150/thno.97162.


Cbfβ regulates Wnt/β-catenin, Hippo/Yap, and Tgfβ signaling pathways in articular cartilage homeostasis and protects from ACLT surgery-induced osteoarthritis.

Chen W, Lu Y, Zhang Y, Wu J, McVicar A, Chen Y Elife. 2024; 13.

PMID: 38805545 PMC: 11132684. DOI: 10.7554/eLife.95640.


References
1.
Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V . The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc. 2009; 4(11):1591-613. DOI: 10.1038/nprot.2009.152. View

2.
Valdes F, Alvarez A, Locascio A, Vega S, Herrera B, Fernandez M . The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res. 2002; 1(1):68-78. View

3.
Pichler A, Gast A, Seeler J, Dejean A, Melchior F . The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 2002; 108(1):109-20. DOI: 10.1016/s0092-8674(01)00633-x. View

4.
Stegmuller J, Huynh M, Yuan Z, Konishi Y, Bonni A . TGFbeta-Smad2 signaling regulates the Cdh1-APC/SnoN pathway of axonal morphogenesis. J Neurosci. 2008; 28(8):1961-9. PMC: 6671436. DOI: 10.1523/JNEUROSCI.3061-07.2008. View

5.
Kim S, Jho E . The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem. 2010; 285(47):36420-6. PMC: 2978571. DOI: 10.1074/jbc.M110.137471. View